F16 Hallucinogen Abuse ICD-10 Code Documentation Guide

F16 documentation starts with the code family

F16 is the ICD-10-CM code family for hallucinogen-related disorders. For hallucinogen abuse documentation, clinicians are usually working within the F16.1- subcategory, with additional characters used when the clinical record supports a more specific presentation, such as uncomplicated abuse, remission, intoxication, or a hallucinogen-induced condition.

The key documentation point is this: the code alone does not tell the clinical story. A progress note should show why the selected diagnosis is clinically relevant to the session, how hallucinogen use is affecting the client’s functioning, what interventions were provided, and what the next care step will be.

AutoNotes does not assign diagnoses for clinicians. Diagnosis selection remains the responsibility of the treating professional, based on clinical assessment, scope of practice, payer requirements, and the current ICD-10-CM code set. AutoNotes can help create structured, editable documentation after the clinician has determined what needs to be recorded.

What F16.1- hallucinogen abuse documentation should support

For an F16.1- hallucinogen abuse code, the note should connect reported or observed hallucinogen use to clinically significant concerns. That may include impairment at work or school, relationship conflict, increased anxiety, risky behavior, legal or housing problems, or continued use despite negative consequences.

Clear documentation usually addresses four areas:

• Substance use pattern: type of hallucinogen reported, frequency, recency, route if clinically relevant, and context of use.
• Functional impact: missed obligations, impaired judgment, interpersonal conflict, safety concerns, or disruption to treatment goals.
• Clinical presentation: mood, anxiety, sleep, perception, thought process, insight, motivation for change, and mental status observations.
• Session response: client engagement, response to interventions, readiness to reduce or stop use, and agreed next steps.

Documentation does not need to be lengthy to be useful. A concise note that links symptoms, impairment, intervention, and plan is often stronger than a long note filled with vague language.

Common F16 code contexts in behavioral health records

Clinicians may encounter F16 codes during intake assessments, individual therapy, substance use counseling, crisis follow-up, psychiatric evaluation, or treatment plan reviews. The same diagnosis can require different documentation depending on the service provided.

Use the current ICD-10-CM code set and payer guidance before finalizing a code. Some systems require the most specific available code rather than the broader category.

Progress note details that make F16 documentation clearer

An F16-related progress note should show what happened in the session, not just repeat the diagnosis. If the note says only “client discussed substance use,” it may be hard for another provider, auditor, or future version of yourself to understand the clinical rationale.

More useful documentation might include: “Client reported using psilocybin twice in the past month, with one episode followed by panic symptoms, missed work the next morning, and conflict with partner. Client identified use as inconsistent with treatment goal of improving emotional regulation.”

That sentence gives the reader substance type, frequency, consequence, and relevance to the treatment plan. It also avoids overstating what was assessed. If the clinician did not assess intoxication, psychosis, or dependence criteria, the note should not imply that those determinations were made.

Intake documentation

During intake, document history and current presentation. Include age of first use if relevant, recent use, prior treatment, withdrawal or intoxication concerns as assessed, co-occurring mental health symptoms, medical factors, medications, and current risk. If the client reports perceptual disturbances, paranoia, panic, or dissociation, describe onset, duration, severity, and whether symptoms occur only during or after use.

Ongoing therapy documentation

For follow-up sessions, connect the session to the treatment plan. Describe changes in use, triggers, coping skills, motivation, relapse prevention work, harm reduction planning where clinically appropriate, and client response. Avoid copying the same substance use paragraph into every note unless the information was actually reviewed.

Crisis or safety-related documentation

If hallucinogen use is associated with suicidal ideation, self-harm, violence risk, impaired judgment, medical concerns, or acute psychotic symptoms, the note should include a risk assessment and the clinical action taken. That may include safety planning, higher level-of-care referral, coordination with emergency supports, or consultation within the clinician’s scope and setting.

How to describe symptoms without overdocumenting beyond the evidence

Hallucinogen-related notes often involve symptoms that need careful language. A client may describe visual changes, panic, paranoia, spiritual experiences, derealization, insomnia, or mood shifts. The clinician’s job is to document what was reported, observed, assessed, and clinically interpreted.

Use specific phrases such as:

• “Client reported transient visual distortions during use; no current hallucinations observed or reported in session.”
• “Client described increased anxiety for approximately 24 hours after use and identified avoidance of work responsibilities the following day.”
• “Client denied current suicidal ideation, homicidal ideation, and command hallucinations; safety plan reviewed.”
• “Clinician provided motivational interviewing focused on ambivalence about continued use.”

This type of wording separates client report from clinician observation. It also helps avoid implying a hallucinogen-induced disorder unless the clinician has assessed and documented that presentation.

F16 treatment planning considerations

Treatment plans for hallucinogen abuse should be tied to the client’s goals and clinical risks. For one client, the focus may be reducing panic symptoms and improving work attendance. For another, it may be abstinence, relapse prevention, coordination with a substance use provider, or managing co-occurring trauma symptoms.

Goals and objectives should be measurable enough to review. Instead of “client will reduce substance use,” a more useful objective might be: “Client will identify three triggers for hallucinogen use and practice two alternative coping strategies before the next treatment plan review.”

Common treatment plan elements include:

• Motivation and insight: explore ambivalence, values, perceived benefits, and consequences of use.
• Risk reduction: identify high-risk settings, impaired judgment concerns, unsafe combinations, and support contacts.
• Coping skills: build alternatives for anxiety, social pressure, boredom, emotional distress, or trauma reminders.
• Care coordination: consider referral or collaboration for substance use treatment, psychiatric care, medical evaluation, or higher level of care when indicated.

The plan should match the severity and acuity documented in the assessment. A client with occasional use and mild impairment may not need the same plan as a client experiencing recurrent intoxication, severe anxiety, or psychotic symptoms after use.

Example F16.10 progress note language

The following fictional example shows how a clinician might document a session involving hallucinogen abuse. It is not a template for diagnosis assignment. The treating clinician is responsible for selecting and confirming the appropriate diagnosis code.

Diagnosis: F16.10 Hallucinogen abuse, uncomplicated, clinician-selected

Data: Client reported using LSD once since last session and stated use occurred after conflict with roommates. Client reported missing one work shift the next morning due to poor sleep and anxiety. Client denied current intoxication, suicidal ideation, homicidal ideation, and current hallucinations. Affect anxious but congruent with content. Thought process logical and goal directed. Session focused on identifying triggers, reviewing recent consequences, and discussing client’s ambivalence about continued use.

Assessment: Client demonstrates increased awareness of the connection between hallucinogen use, anxiety symptoms, and occupational impairment. Client remains ambivalent about abstinence but expressed interest in reducing use and avoiding use during periods of emotional distress. No acute safety concerns identified during session based on client report and clinician assessment.

Plan: Continue weekly therapy. Use motivational interviewing and CBT-based coping skills to address triggers, anxiety, and decision-making. Client will track urges, mood, sleep, and substance use before next session. Review treatment goal related to reducing substance-related impairment at next visit.

Documentation gaps that can weaken F16 notes

Many F16 notes fall short because they name the substance concern but do not document the clinical connection. A stronger note shows how use affects functioning and what the clinician did in response.

Small documentation changes can make the record more clinically useful. They also help the next provider understand the client’s current needs without reading between the lines.

How AutoNotes supports clinician-reviewed F16 documentation

AutoNotes helps behavioral health professionals create structured, editable progress note drafts for sessions involving substance use concerns, including hallucinogen-related documentation. The clinician remains in control of the diagnosis, clinical interpretation, edits, and final note.

Compared with a generic AI writing tool, AutoNotes is built around therapy documentation workflows. Clinicians can draft notes that include interventions, client response, mental status details, treatment plan links, and follow-up steps in formats such as SOAP, DAP, BIRP, intake summaries, and treatment plans.

• Service-specific templates: draft notes for individual therapy, intake, assessment, treatment planning, and other behavioral health services.
• Editable clinical language: revise wording to match your assessment, scope, documentation standards, and client presentation.
• Consistency across sessions: keep progress notes organized around symptoms, interventions, response, risk, and plan.
• Faster first drafts: reduce the time spent starting from a blank note while preserving clinician review.

If F16 documentation is taking extra time after sessions, AutoNotes can give you a structured starting point. Start your free trial and review an editable note draft before using it in your clinical record.